My Treatment Approach: Optimizing Treatment for Chronic GVHD

home / insights / my-treatment-approach-optimizing-treatment-for-chronic-gvhd

This educational program, led by experts Shernan Holtan, MD, and Haris Ali, MD, explores the latest strategies and emerging treatments for optimizing management of chronic graft-vs-host disease (cGVHD), including monitoring techniques, therapeutic options, and patient-reported outcomes.

Differentiating Acute and Chronic Graft-vs-Host Disease

EP. 1: Differentiating Acute and Chronic Graft-vs-Host Disease

Shernan Holtan, MD;Haris Ali, MD, City of Hope
August 29th 2024

After a brief introduction, Shernan Holtan, MD, and Haris Ali, MD, discuss the distinction between acute and chronic graft-vs-host disease.

Navigating Chronic GVHD: Phases of Pathophysiology and Best Practices in Patient Monitoring

EP. 2: Navigating Chronic GVHD: Phases of Pathophysiology and Best Practices in Patient Monitoring

Shernan Holtan, MD;Haris Ali, MD, City of Hope
August 29th 2024

Medical experts discuss navigating chronic GVHD.

Optimizing Chronic GVHD Therapy

EP. 3: Optimizing Chronic GVHD Therapy

Shernan Holtan, MD;Haris Ali, MD, City of Hope
September 5th 2024

Medical experts discuss overall goals for cGVHD treatment as well as concerns with long-term corticosteroid use in treatment.

Navigating Treatment Decisions in Chronic GVHD

EP. 4: Navigating Treatment Decisions in Chronic GVHD

Shernan Holtan, MD;Haris Ali, MD, City of Hope
September 5th 2024

Medical experts discuss criteria for switching GVHD treatments and how to choose between available treatment options.

Overview of Advanced Therapies in cGVHD

EP. 5: Overview of Advanced Therapies in cGVHD

Shernan Holtan, MD;Haris Ali, MD, City of Hope
September 12th 2024

Medical experts discuss advanced therapies in cGVHD.

Overview of the ROCKstar Study

EP. 6: Overview of the ROCKstar Study

Shernan Holtan, MD;Haris Ali, MD, City of Hope
September 12th 2024

Medical experts discuss the data that led to belumosudil’s FDA approval.